石四药集团：盐酸贝尼地平片获得药品生产注册批件

Group 1 - The company, Shijiazhuang Pharmaceutical Group, has obtained the drug production registration certificate from the National Medical Products Administration of China for Benidipine Hydrochloride Tablets (8mg), classified as a Class 4 chemical drug, which is considered to have passed the consistency evaluation [1] - Benidipine Hydrochloride Tablets are primarily used for the treatment of essential hypertension and angina pectoris [1] - The company's raw material for Benidipine Hydrochloride has also been approved by the National Medical Products Administration for use in marketed formulations, as stated in the company's announcement dated January 6, 2025 [1]